Home » Topics » BioWorld Science

BioWorld Science
RSS

SentiBio presents novel allogenic cell therapy, SENTI-101

Nov. 13, 2019

Chugai Pharmaceuticals presents phase I data for EOS-789

Nov. 13, 2019

Preclinical and preliminary first-in-human data presented for STRO-002

Nov. 13, 2019

DCC-3116 as a promising inhibitor of autophagy in preclinical models of RAS-mutant cancers

Nov. 13, 2019

New data presented for ParvOryx in human ovarian cancer explants

Nov. 13, 2019

FDA places on hold the phase I/II IGNITE DMD study of SGT-001

Nov. 13, 2019

FDA approves IND for WP-1066

Nov. 13, 2019

24-week data presented from HMM0301 phase III monotherapy study of dorzagliatin

Nov. 13, 2019

RNA controls muscle stem cells

Nov. 13, 2019

Case study points to protective AD gene

Nov. 13, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...